Lacosamide Vivanta

Lacosamide, the active ingredient in Lacosamide Vivanta, is a anti‑epileptic (sodium channel blocker) presented as an intravenous solution for intravenous use. It is used as adjunctive therapy for partial‑onset seizures in adult patients. GNH USA supplies Lacosamide Vivanta as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Lacosamide is an anti‑epileptic drug that acts on neuronal sodium channels to control seizure activity. - Partial‑onset seizures (focal seizures): reduces seizure frequency when added to existing antiepileptic therapy. - Adjunctive therapy in epilepsy: provides additional seizure control for adults with refractory epilepsy. - Seizure management in adults: improves overall seizure control as part of combination treatment.

Lacosamide may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Headache: mild to moderate pain in the head region. - Nausea: feeling of stomach upset or urge to vomit. - Fatigue: unusual tiredness or lack of energy. - Blurred vision: temporary visual disturbances. - Somnolence: increased sleepiness or drowsiness.

Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heart rhythm requiring medical attention. - Suicidal ideation: thoughts of self‑harm that need immediate evaluation. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Respiratory depression: reduced breathing effort, especially with CNS depressants.

Before initiating therapy, consider patient‑specific factors and monitor for potential risks. - Renal impairment: assess kidney function and adjust monitoring as needed. - Cardiac conduction disorders: obtain baseline ECG and watch for PR‑interval changes. - Pregnancy: safety category unknown; weigh benefits against potential risks. - Concomitant CNS depressants: use caution due to additive sedative effects. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Lacosamide can interact with several medications, influencing its efficacy or safety.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors: may increase lacosamide plasma concentrations. - Strong CYP3A4 inducers: may reduce lacosamide effectiveness. - Other sodium channel blockers: risk of additive central nervous system effects.

Moderate Interactions (Monitor Closely): - Carbamazepine: may lower lacosamide levels, reducing seizure control. - Phenytoin: can increase dizziness and coordination problems. - Alcohol: may enhance sedation and impair alertness.